I want to know the answer to the following question:
Despite FDA approval, how much more likely to die are patients who take bedaquiline in addition to the standard TB regimen?
All the background I'm provided with is that "The safety and effectiveness of these new agents are still uncertain, because they are based on the results of a relatively small studies.". Is that enough to answer the question?